Literature DB >> 23200770

Heat shock protein 90AB1 and hyperthermia rescue infectivity of HIV with defective cores.

Pheroze Joshi1, Barbara Sloan, Bruce E Torbett, Cheryl A Stoddart.   

Abstract

We previously showed that reduced infectivity of HIV with incompletely processed capsid-spacer protein 1 (CA-SP1) is rescued by cellular activation or increased expression of HSP90AB1, a member of the cytosolic heat shock protein 90 family. Here we show that HSP90AB1 is present in HIV virions and that HSP90AB1, but not nonfunctional mutated HSP90AB1(E42A+D88A), restores infectivity to HIV with mutations in CA that alter core stability. Further, the CA mutants were hypersensitive to pharmacological inhibition of HSP90AB1. In agreement with Roesch et al. (2012), we found that culturing HIV at 39.5°C enhanced viral infectivity up to 30-fold in human peripheral blood mononuclear cells (p=0.002) and rescued CA-mutant infectivity in nonactivated cells, concurrent with elevated expression of HSP90AB1 during hyperthermia. In sum, the transdominant effect of HSP90AB1 on CA-mutant HIV infectivity suggests a potential role for this class of cellular chaperones in HIV core stability and uncoating.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23200770      PMCID: PMC3563299          DOI: 10.1016/j.virol.2012.11.005

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  40 in total

1.  Functional surfaces of the human immunodeficiency virus type 1 capsid protein.

Authors:  Uta K von Schwedler; Kirsten M Stray; Jennifer E Garrus; Wesley I Sundquist
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 2.  The Hsp90 chaperone machinery: conformational dynamics and regulation by co-chaperones.

Authors:  Jing Li; Joanna Soroka; Johannes Buchner
Journal:  Biochim Biophys Acta       Date:  2011-09-16

Review 3.  Inhibitors of the heat shock response: biology and pharmacology.

Authors:  Marissa V Powers; Paul Workman
Journal:  FEBS Lett       Date:  2007-05-25       Impact factor: 4.124

4.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

Review 5.  HSP90 and the chaperoning of cancer.

Authors:  Luke Whitesell; Susan L Lindquist
Journal:  Nat Rev Cancer       Date:  2005-10       Impact factor: 60.716

6.  Discrimination between exosomes and HIV-1: purification of both vesicles from cell-free supernatants.

Authors:  Réjean Cantin; Juliette Diou; Dave Bélanger; Alexandre M Tremblay; Caroline Gilbert
Journal:  J Immunol Methods       Date:  2008-07-31       Impact factor: 2.303

7.  Purification of HIV-1 virions by subtilisin digestion or CD45 immunoaffinity depletion for biochemical studies.

Authors:  David E Ott
Journal:  Methods Mol Biol       Date:  2009

Review 8.  Cellular kinases incorporated into HIV-1 particles: passive or active passengers?

Authors:  Charline Giroud; Nathalie Chazal; Laurence Briant
Journal:  Retrovirology       Date:  2011-09-02       Impact factor: 4.602

9.  Virus-producing cells determine the host protein profiles of HIV-1 virion cores.

Authors:  Steven Santos; Yuri Obukhov; Sergei Nekhai; Michael Bukrinsky; Sergey Iordanskiy
Journal:  Retrovirology       Date:  2012-08-13       Impact factor: 4.602

10.  Evidence for direct involvement of the capsid protein in HIV infection of nondividing cells.

Authors:  Masahiro Yamashita; Omar Perez; Thomas J Hope; Michael Emerman
Journal:  PLoS Pathog       Date:  2007-10-26       Impact factor: 6.823

View more
  8 in total

Review 1.  HSP90AB1: Helping the good and the bad.

Authors:  Michael Haase; Guido Fitze
Journal:  Gene       Date:  2015-09-07       Impact factor: 3.688

2.  HSF1 Activation Can Restrict HIV Replication.

Authors:  Emmanuel E Nekongo; Anna I Ponomarenko; Mahender B Dewal; Vincent L Butty; Edward P Browne; Matthew D Shoulders
Journal:  ACS Infect Dis       Date:  2020-06-10       Impact factor: 5.084

Review 3.  Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature.

Authors:  Jean-François Gélinas; Deborah R Gill; Stephen C Hyde
Journal:  Microbiol Mol Biol Rev       Date:  2018-01-10       Impact factor: 11.056

4.  Quiescence Promotes Latent HIV Infection and Resistance to Reactivation from Latency with Histone Deacetylase Inhibitors.

Authors:  Mark M Painter; Thomas D Zaikos; Kathleen L Collins
Journal:  J Virol       Date:  2017-11-30       Impact factor: 5.103

5.  The microvesicle component of HIV-1 inocula modulates dendritic cell infection and maturation and enhances adhesion to and activation of T lymphocytes.

Authors:  Sarah K Mercier; Heather Donaghy; Rachel A Botting; Stuart G Turville; Andrew N Harman; Najla Nasr; Hong Ji; Ulrike Kusebauch; Luis Mendoza; David Shteynberg; Kerrie Sandgren; Richard J Simpson; Robert L Moritz; Anthony L Cunningham
Journal:  PLoS Pathog       Date:  2013-10-17       Impact factor: 6.823

Review 6.  Diversity in heat shock protein families: functional implications in virus infection with a comprehensive insight of their role in the HIV-1 life cycle.

Authors:  Kruthika Iyer; Kailash Chand; Alapani Mitra; Jay Trivedi; Debashis Mitra
Journal:  Cell Stress Chaperones       Date:  2021-07-27       Impact factor: 3.667

7.  Transcriptome analysis of primary monocytes from HIV-positive patients with differential responses to antiretroviral therapy.

Authors:  Jing Qin Wu; Tara Ruth Sassé; Monica Miranda Saksena; Nitin K Saksena
Journal:  Virol J       Date:  2013-12-27       Impact factor: 4.099

8.  Inhibition of Heat Shock Protein 90 Prevents HIV Rebound.

Authors:  Pheroze Joshi; Ekaterina Maidji; Cheryl A Stoddart
Journal:  J Biol Chem       Date:  2016-03-08       Impact factor: 5.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.